杀线虫芽孢杆菌发酵条件优化及大孔树脂筛选

芽孢杆菌 SMrs28分离自草原毒草瑞香狼毒根际土壤,其代谢产物有明显的线虫触杀活性。为了确定该菌株的最优发酵条件及初步纯化活性成分的树脂类型,采用单因素试验对发酵条件进行优化,通过静态吸附试验对大孔树脂类型进行筛选。结果表明: SMrs28菌株的最优发酵条件为:以葡萄糖和酵母粉作为最佳碳源和氮源,发酵时间48 h,接种量10%,温度28 ℃,转速180 r·min^-1,150 mL的三角瓶装液量30 mL,初始pH 7.2。静态吸附试验表明,大孔吸附树脂D101对发酵液中活性成分的吸附和解吸效果显著优于XAD-4、HP20和AB-8,其解吸液的杀线虫活性明显提高。发酵条件的优化和大孔吸附树脂的筛选,明显提高了发酵液的杀线虫活性,为进一步分离纯化该菌株的活性成分奠定了基础,为微生物杀线虫剂的开发和应用提供了理论依据。     

浅紫灰链霉菌CQ01819及其次级代谢产物的定向发掘

【目的】采用特征次级代谢产物生物合成的保守功能基因探针,定向分离土壤中产生特征次级代谢产物的菌种资源,借助基因转录分析为导向的培养基优化方法,获得目标次生代谢产物。【方法】首先,根据5种特征次级代谢产物保守的合成功能基因设计简并引物,定向从土壤样品中筛选、分离并纯化菌株。然后,以RT-qPCR为指导开展目标产物的发酵培养基优化;最后,对菌株进行发酵,利用多种色谱技术分离纯化目标天然产物,并结合高分辨质谱与核磁共振等技术对所获得的化合物进行结构鉴定。【结果】从土壤中筛选得到了一株AHBA合酶基因和环氧化酶基因均为阳性的链霉菌菌株(编号为CQ01819),根据转录分析优化发酵培养基,最终从该菌株分离纯化得到了含有AHBA结构单元的丝裂霉素C、聚醚类抗生素莫能霉素A和缬吲霉素。【结论】本研究通过菌株的定向分离纯化,筛选得到了产生预期抗生素的浅紫灰链霉菌菌株CQ01819;基于RT-qPCR指导的发酵培养基优化,确定了菌株的发酵条件;获得发酵粗提物后,采用多种色谱整合技术和光谱分析策略,快速分离并鉴定了目标产物。该研究为目标菌种资源的定向筛选、菌株的发酵条件的快速优化和化合物的定向分离提供了较好的参考。     

杜仲醇的制备及其表征

采用大孔吸附树脂-制备液相色谱联用技术分离制备杜仲醇。以杜仲叶为原料,采用超声波辅助提取,提取液经过正丁醇萃取、D101大孔吸附树脂柱分离纯化后,再通过反相半制备液相色谱分离,以V(甲醇):V(水)=15∶85为流动相进行洗脱,制备得到杜仲醇单体。采用紫外光谱(UV)、红外光谱(IR)、核磁共振波谱(NMR)及液相色谱-质谱联用(LC-MS)等方法对所得单体进行了结构验证。液相色谱法分析检测表明制备所得杜仲醇纯度达95.12%。     

大孔吸附树脂结合半制备型高效液相色谱分离纯化栝楼果皮中的水溶性化学成分(英文)北大核心CSCD

本文使用大孔吸附树脂结合半制备型高效液相色谱,对栝楼果皮中的水溶性化学成分进行了分离纯化。栝楼果皮水溶性粗提物经大孔吸附树脂粗分为4个部分,每一部分分别使用半制备型高效液相色谱进一步纯化,最终得到3种核苷酸及6种碱基,其化学结构经紫外光谱及核磁共振鉴定为:胞嘧啶、尿嘧啶、次黄嘌呤、鸟嘌呤、黄嘌呤、腺嘌呤、鸟苷、6-异次黄嘌呤核苷及腺苷。本文对于栝楼果皮中水溶性化学成分进行了较为系统的研究,建立起来的分离纯化方法具有简单、快速、经济和易于放大的优点,适合于天然产物中强极性活性成分的大规模制备。     

鸡枞发酵菌粉中皂苷的大孔树脂分离纯化

目的:研究大孔吸附树脂纯化鸡枞皂苷的方法.方法:采用分光光度法测定鸡枞皂甙的含量,分别考察了树脂种类、样品液浓度、pH值、吸附流速、洗脱剂浓度对鸡枞皂甙分离纯化的影响.结果:HPD-450树脂最适合鸡枞皂苷的纯化.工艺条件为:洗脱剂乙醇的体积分数为40%,吸附流速为1～2mL/min,样品液浓度为2.5～4.0mg/mL,样品液pH值为5～7.采用HPD-450大孔吸附树脂对鸡枞皂甙进行纯化效果最优.结论:在上述条件下,大孔树脂可用于鸡枞皂甙的分离纯化.     

大孔吸附树脂结合半制备型高效液相色谱分离纯化栝楼果皮中的水溶性化学成分（英文）

本文使用大孔吸附树脂结合半制备型高效液相色谱,对栝楼果皮中的水溶性化学成分进行了分离纯化。栝楼果皮水溶性粗提物经大孔吸附树脂粗分为4个部分,每一部分分别使用半制备型高效液相色谱进一步纯化,最终得到3种核苷酸及6种碱基,其化学结构经紫外光谱及核磁共振鉴定为:胞嘧啶、尿嘧啶、次黄嘌呤、鸟嘌呤、黄嘌呤、腺嘌呤、鸟苷、6-异次黄嘌呤核苷及腺苷。本文对于栝楼果皮中水溶性化学成分进行了较为系统的研究,建立起来的分离纯化方法具有简单、快速、经济和易于放大的优点,适合于天然产物中强极性活性成分的大规模制备。     

枯草芽孢杆菌内切木聚糖酶的分离纯化与鉴定

目的：建立一种简便、快速的木聚糖酶分离和提取方法。方法：采用活性聚丙烯酰胺凝胶电泳和均质提取法相结合,分离纯化枯草芽孢杆菌(Bacillus subtilis)固体培养基发酵产物中的木聚糖酶,进一步用薄层色谱和高压液相色谱对木聚糖酶进行鉴定。结果：采用活性聚丙烯酰胺凝胶电泳和均质提取法相结合,从枯草芽孢杆菌(Bacillus subtilis)固体培养基发酵产物中分离得到了两种内切木聚糖酶,酶解桦木木聚糖的产要产物以木二糖和木三糖为主。结论：活性聚丙烯酰胺凝胶电泳和均质提取法相结合是一种新的分离纯化木聚糖酶的简便、有效方法。     

藤黄灰链霉菌-H103发酵液中抗真菌活性成分的分离纯化*

通过大孔树脂吸附等方法对藤黄灰链霉菌H103发酵液中的抗真菌活性成分进行了分离纯化,得到了纯度较高的活性物质的结晶,并且建立了通过大孔树脂吸附-结晶的分离纯化路线以及反相高压液相色谱-蒸发光散射(HPLC-ELSD)的检测方法,为进一步的理化性状研究打下了一个良好的基础。实验表明,最佳吸附树脂为X-5树脂,洗脱剂为50%乙醇,HPLC条件为:反相色谱柱Agilent 20RBA×310SB-C18(150mm×4.6mm I.d,5μm),以乙腈(A)-水(B)为流动相,梯度洗脱,0~4.0m in,V(     

棘孢曲霉转化甜菊糖为甜菊醇及纯化莱鲍迪苷A

【目的】本工作对棘孢曲霉固体发酵抽提酶液转化甜菊糖进行了研究,并对转化产物进行鉴定及纯化分析。【方法】用高效液相色谱、液质联用及红外光谱等方法对转化新产物进行鉴定,对上清液中莱鲍迪苷A(RA)成分进行纯化。【结果】棘孢曲霉酶液在10 h内对甜菊糖中的甜菊苷(SS)、莱鲍迪苷C(RC)进行高效特异性转化,以沉淀的形式析出的转化产物经鉴定为甜菊醇,转化率高达98.0%,分离提纯后纯度为95.2%,回收率达84.0%.由于甜菊醇的沉淀分离,留在溶液中的RA更易被纯化。RA通过树脂吸附分离的回收率为80.5%.【结论】棘孢曲霉酶液对甜菊糖的一次转化可以同时得到甜菊醇和莱鲍迪苷A两种产品,是一种经济高效的工艺。     

产胶原酶的蜡样芽胞杆菌发酵条件优化及酶的分离纯化

【目的】优化蜡样芽胞杆菌R75E菌株产胶原酶的条件,并通过蛋白分离纯化技术获得高纯度胶原酶。【方法】利用单因素及正交试验优化蜡样芽胞杆菌R75E产胶原酶的发酵条件及发酵培养基,将发酵液离心除菌后得到粗酶液,对其依次通过硫酸铵分级沉淀、Butyl FF疏水层析及SuperdexTM 200凝胶过滤层析等方法对目标胶原酶进行分离纯化,利用SDS-PAGE电泳检测其纯度。【结果】优化后发酵条件为培养温度41°C、接种量6%、培养时间36 h,优化后发酵培养基为葡萄糖10 g/L、蛋白胨5 g/L、起始p H 7.0,粗酶液酶活力较优化前提高了2.9倍;将该粗酶液经过一系列纯化后得到纯度超过90%的胶原酶产物,其纯化倍数和回收率分别为18.4和1.1%。【结论】获得蜡样芽胞杆菌R75E的最佳产酶条件,并对胶原酶分离纯化的方法进行了探索,为微生物胶原酶的开发应用奠定基础。     

Computer modeling of antibiotic fermentation with on-line product removal

The fermentation of Streptomyces griseus for the production of cycloheximide is similar to other antibiotic fermentations in that product synthesis is subject to feedback regulation and the desired product is degraded in the fermentation broth. The productivity of this fermentation can thus be dramatically increased by removing the antibiotic from the whole broth as it is produced. One means for effecting this on-line product removal is to contact the whole fermentation broth with neutral polymeric resin immobilized in hydrogel beads. The antibiotic adsorbs to the immobilized resin via hydrophobic interactions. In this work, the adsorption of the antibiotic onto the immobilized resin was characterized. A biochemical model of the fermentation was then used to describe the time profiles of biomass, substrate, and antibiotic in a fermentation system in which whole broth is circulated from the fermentor through a continuously stirred extractor containing the adsorbent beads. Various operating conditions were examined to optimize the productivity of the fermentation.     

L-缬氨酸发酵培养基的神经网络建模与遗传算法优化

运用神经网络对L-缬氨酸发酵培养基组成进行建模,在神经网络模型的基础上采用遗传算法对培养基组成进行优化,得到最佳发酵培养基组成.结果表明,运用神经网络并结合遗传算法是一种行之有效的优化方法.按最佳发酵培养基组成进行发酵实验64h,可在发酵液中积累L-缬氨酸28.5g/L.     

Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity

Pharmacokinetic parameters of eremomycin (Institute of New Antibiotics, the USSR Academy of Medical Sciences), teichoplanin (Lepetit) and vancomycin (Eli Lilly) were compared after their intravenous administration to rats in the same dose of 50 mg/kg. It was shown that the area under the concentration time curve of eremomycin was 2 times smaller than that of teichoplanin and 6 times larger than that of vancomycin. The mean retention time of eremomycin was close to that of teichoplanin and 1.6 times higher than that of vancomycin. Bioavailability of eremomycin and teichoplanin after their extravascular administration was the same and amounted to 94 per cent. Antibacterial activity of eremomycin against methicillin resistant strains of staphylococci was 4 times higher than that of teichoplanin and vancomycin.     

L-苏氨酸工业生产发酵条件优化研究

发酵法生产L-苏氨酸是目前广泛采用的方法,因此研究工业生产发酵条件优化具有重要意义。试验以高产L-苏氨酸菌作为出发菌株,结合本公司的实际工业生产条件对发酵各条件进行了一系列优化研究,结果表明：添加0.2%的工业级生长促进剂,以复合糖代替葡萄糖为初糖,并控制初糖浓度在60g/L,除生长高峰期外,发酵过程中溶解氧（DO）控制在10%~20%之间;最终发酵放罐湿菌体在45g/L左右,L-苏氨酸含量可达110g/L左右。     

重组人抗凝血酶发酵条件的优化

目的:通过实验室发酵条件优化工作,实现在巴斯德毕赤酵母中高效表达重组人抗凝血酶。方法:在摇瓶培养条件下,应用正交实验方法考查人抗凝血酶重组毕赤酵母菌pPIC9K-AT-02的培养温度、培养基pH值、接种比例、甲醇补加间隔时间及甲醇补加浓度等5种因素对重组人抗凝血酶活性的影响,确定最优发酵条件。结果与结论:筛选出的最终发酵条件为培养温度30℃、培养基pH6.0、接种比例20%、甲醇补加间隔时间24 h、甲醇补加浓度2%,重组人抗凝血酶在巴斯德毕赤酵母中表达活性为4098 U/L,比原始活性提高了150%。     

The structure of antibiotic eremomycin B

A new biologically active component, antibiotic eremomycin B, was isolated from the culture liquid of Amycolatopsis orientalis subsp. eremomycini, the producing strain for antibiotic eremomycin. Its structure was established by NMR spectroscopy and mass spectrometry. Eremomycin B was shown to differ from eremomycin by the presence of an N-carboxymethyl substituent in the disaccharide eremosamine fragment.     

The structure and antimicrobial activity of the partial degradation products of the antibiotic eremomycin

Antimicrobial activity of partial degradation products of eremomycin, a new glycopeptide antibiotic, was studied. The products formed by eremomycin deglycosylation (deseremosaminyl eremomycin, eremosaminyl aglycone and aglycone) and elimination of the chlorine atom from the molecule aglycone moiety (dechloroeremomycin). The spectral data in favour of the compounds structure are presented. It was found that partial degradation led to a decrease in the antimicrobial activity of the antibiotic. Dechloreremomycin had the highest activity among the products. Its MIC for the methicillin-resistant strains of Staphylococcus aureus was only twice as low as that of the initial antibiotic.     

纳豆激酶发酵液的脱色工艺研究

从11种待选脱色介质中筛选出330(OH)型树脂对纳豆激酶发酵液进行脱色研究.结果表明:(1)330(OH)型树脂对纳豆激酶发酵液中的色素为优吸型吸附,其动力学模型符合扩散方程,其动力学拟和方程为-ln(1-F)=0.0223t+0.0511,R2=0.9978,其中F=Qt/Qe,Qt为脱色时间为t时330(OH)型...     

Eremomycin in the treatment of antibiotic-associated colitis in golden hamsters]

The efficacy of eremomycin, a new glycopeptide antibiotic, was studied on a model of antibiotic-associated colitis in golden hamsters. The colitis was induced by intraperitoneal or intragastric administration of lincomycin. In a dose of 100 mg/kg administered orally once a day for 5 days eremomycin protected the animals from the lincomycin-induced colitis: some animals survived, the others died in later periods. When the animals were infected with a pathogenetic strain of Clostridium difficile followed by exposure to lincomycin the use of eremomycin produced the similar effect.     

Effect of the seeding culture media on the biosynthesis of eremomycin

Relationship of eremomycin biosynthesis to the quantity and quality of the inoculate (age, aeration rate, number of subcultures) was studied. The seed medium composition for cultivating the inoculate was defined. A procedure for cultivation of the seed material for biosynthesis of eremomycin providing an increase in the antibiotic yield by 24 per cent was developed.